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ABSTRACT
Induction of Differentiation of Dental Pulp-Derived Mesenchymal Stem Cells
(DPSC)

By
Aubrey Young

Dr. Karl Kingsley, Examination Committee Chair
Associate Professor of Biomedical Sciences
Director of Student Research
University of Nevada, Las Vegas
School of Dental Medicine
Mesenchymal stem cells are derived from a variety of human tissues and are
being bioengineered and studied for possible uses in the advancement of medicine.
Recent efforts are being focused on Dental Pulp Stem Cells (DPSC’s) due to the
accessibility of this tissue. Many factors inﬂuence DPSC quality and quantity, including
the speciﬁc methods used to isolate, collect, concentrate, and store these isolates once
they are removed. Ancillary factors, such as the choice of media, the selection of early
versus late passage cells, and cryopreservation techniques may also influence the
differentiation potential and proliferative capacity of DPSC isolates.
The objective of this study was to evaluate the potential to induce differentiation
of DPSC isolates in vitro by the adding of exogenous growth factors (GF), and by the
coating of specific extracellular matrix molecules (ECM) onto the surface of tissueculture dishes. Photomicroscopy and mRNA analysis demonstrated the addition of TGFβ1 notably increased pluripotency biomarkers in DPSC lines. The addition of
iii

Dexamethasone (Dex) or plating on Laminin-5 (LN5) was correlated with changes to
cellular morphology and cell size in different subsets of cells. RNA isolated from these
DPSCs for relative endpoint (RE) reverse transcription polymerase chain reaction (RTPCR) revealed mRNA DPSC specific intracellular biomarkers (Klf4, Sox-2, Bin-1,
Rnf12, Oct-4 and NANOG) and the cell surface marker (CD133) were enhanced
following the administration of TGF- β 1 and were differentially down-regulated
following Dexamethasone and Laminin-5 administration. This study provides some
initial evidence that randomly selected DPSC isolates may be induced by established
protocols to change phenotype and expression of pluripotent biomarkers with variable
susceptibility between differing types of DPSCs. More studies will be needed to
determine the range of cell types that can be successfully re-engineered in laboratory
settings.
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CHAPTER 1
INTRODUCTION
Background and Significance
The isolation of mesenchymal stem cells (MSC) is an important scientific
endeavor in the health sciences [1, 2]. Although much is known about embryonic stem
cells and their regenerative capacity, recent efforts have focused on MSC because they
are far less controversial, and more importantly, may be derived directly from children
and adult patients [3, 4]. Many tissues, including bone marrow, peripheral blood, heart
tissue, and lung tissue, harbor populations of viable MSCs but more recent efforts have
focused on more accessible sources such as adipose tissue and dental pulp from extracted
teeth [5-9].
A growing body of evidence has suggested that dental pulp-derived stem cells
(DPSC) are among the most accessible of human stem cell populations [10]. DPSCs are
originally formed from both epithelial and mesenchymal stem cell progenitors, the
epithelial-derived ameloblasts and the mesenchymal-derived dentin and bone and soft
tissues of the periodontium [11]. Although they cannot form all cells and tissues of the
body, these DPSCs are capable of differentiation into more than one cell type and are
therefore classified as multipotent stem cells [12]. Studies have now confirmed DPSC,
under specific conditions and stimuli, may be capable of differentiating into adipocytes,
neurons, osteoblasts and chondrocytes although these specific methods could vary by
whether the DPSC were derived from the apical part of the papilla (AP-DPSC), the dental
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follicle (DF-DPSC) surrounding third molars, or the periodontal ligament (PDL-DPSC)
[13,14].
Two nation-wide commercial companies now offer a service for processing and
storing DPSC from either primary teeth or extracted adult teeth, but little information is
known about the differentiation potential of these DPSC isolates [15]. Hung E. et al.
found that premolars and other intact teeth extracted from orthodontic patients ages 18-25
exhibited the greatest likelihood for obtaining viable DPSC isolates [16]. These studies,
however, did not evaluate the potential to induce differentiation in these uncommitted
DPSC lines using established methods and protocols.
Statement of Purpose
The objective of this study was to evaluate the potential to induce differentiation
of DPSC isolates originally derived from extracted teeth of adult orthodontic patients.
The working hypothesis for this project was that any DPSC isolate, derived from vital,
intact permanent adult teeth, could be induced towards differentiation in vitro using
preplated cell-matrix adhesion molecules and the administration of exogenous growth
factors [17, 18].
Orthodontic patients whose treatment includes extractions of teeth should be
educated about the opportunity they have to have their DPSCs banked and stored for
possible use in their future. As orthodontic professionals we have an ethical responsibility
to educate our patients about the benefits of stem cell banking. Understanding more about
how to create usable stem cell isolates will further the progress of regenerative medicine
and will better enable dental care providers to offer valuable education to our patients.
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Research Questions and Hypotheses
1. Dental pulp-derived mesenchymal stem cells (DPSC) can be directed towards a
differentiated phenotype in vitro.
H0: No, potential DPSC isolates cannot be directed towards differentiation in vitro.
HA: Yes, potential DPSC isolates can be directed towards differentiation in vitro.
2. Specific ECM and GF promote differentiation of dental pulp stem cells in vitro.
H0: No, specific ECM and GF do not promote differentiation of DPSC in vitro.
HA: Yes, specific ECM and GF do promote differentiation of DPSC in vitro.
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CHAPTER 2
LITERATURE REVIEW
Many organs and tissues require the ability to replace cells as a normal part of the
aging process, as well as in response to damage, injury or infection [19]. Research has
now revealed that many of these organ and tissue systems have resident populations of
somatic stem cells, which are capable of asymmetrical replication [20]. The process of
asymmetric replication results in two daughter cells – one that retains the undifferentiated
stem cell properties and the other that is capable of replacing dead, dying or injured cells
[21].
Each of the primary germ layers of the developing embryo, ectoderm (or outside
layer), endoderm (or inside layer) and mesoderm (or middle layer) give rise to tissues that
will ultimately host their own populations of resident stem cells [22]. These tissuespecific stem cell populations maybe further classified, based upon their potential for
differentiation into the various cell types found within the tissue or organ system [23].
Although totipotent stem cells from embryonic tissues are capable of differentiating into
every possible cell type found within the body, these are typically harvested from
developmental or fetal tissues – which may limit their availability and potential for
therapeutic use [24]. Most adult tissues host other types of stem cells, including
multipotent, pluripotent and oligopotent stem cells capable of differentiation into more
than one cell type, as well as unipotent stem cells that produce specialized cells of only
one type [25].
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Although adult stem cells may be harvested and retrieved from a variety of tissues
and organs, this may involve costly and invasive procedures, such as bone marrow or
liposuction aspiration [26]. However, recent clinical studies have shown that dental pulp
from extracted teeth may provide an abundant supply of highly proliferative, multipotent
Mesenchymal Stem Cells (MSC), which are now known to be capable of regenerating a
variety of human tissues including bone and other dental structures [27]. In addition,
dental pulp-derived stem cells (DPSC) have also been demonstrated to be capable of
differentiating into many other lineages, including osteoblasts, chondroblasts, adipocytes,
as well as vascular and neural tissues [28].
Sources
Many factors are known to influence DPSC quantity and quality, although one of
the most basic may be the source of the dental pulp itself [14]. For example, some
evidence has recently emerged demonstrating that stem cells from human exfoliated
deciduous (or primary) teeth (SHED) may exhibit faster growth and proliferation, as well
as a more expansive array of potential cellular phenotypes and differentiation potentials
[29]. Additionally, SHED may also exhibit slightly greater rates of survival after shortterm freezing and storage than DPSCs derived from extracted, permanent (adult) teeth
[30]. However, due to the recent nature of these discoveries, the vast majority of the
population is not able to make use of these reservoirs as they have already developed
their permanent dentition, and those currently in need of stem cell therapy are unlikely to
have had an opportunity to save any viable dental pulp from exfoliated primary teeth
[31]. Moreover, some studies have provided evidence that the quantity of healthy pulp
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derived from primary or deciduous teeth may, in fact, be insufficient to productively
harvest SHED [32].
Based upon this knowledge, many researchers are now focused on exploring the
role of permanent or adult teeth as a reservoir for the acquisition of DPSCs [33]. One
possible source of DPSCs from healthy, permanent, adult tooth extraction are orthodontic
clinics, where extraction of premolars and molars remains common practice among the
four million patients in the United States often approaching or exceeding 30% of all
patients [34]. Although no comprehensive review of DPSC by tooth type has been
performed, recent work by this group has revealed that tooth type did not affect either
quality or quantity of DPSC isolates, however, the age of donor was found to be a
significant factor [16]. In fact, the most recent study provides further evidence that
permanent teeth extracted from younger donors may yield DPSCs with higher growth,
proliferation and differentiation without regard to tooth type [35].
Isolation
Other factors may also inﬂuence DPSC quality and quantity, including the
speciﬁc methods used to isolate, collect, concentrate, and store these isolates once they
are removed [16]. For example, the two most common methods used for DPSC isolation
are enzymatic dissociation (DPSC-ED), where enzymes are used to digest the matrix and
other biological materials comprising the dental pulp, and direct outgrowth (DPSC-OG)
which allows for DPSCs to naturally dissociate from the pulp over the course of several
weeks in laboratory cultures [36]. Some studies have demonstrated that DPSC-ED are
more likely to give rise to heterogeneous populations of faster growing cells due to the
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enzymatic activity that may facilitate release of DPSC embedded within this matrix [37].
However, other studies have suggested that cellular damage or destruction may result
from using this method, suggesting that DPSC-OG may be a less a destructive
alternative, although this tends to give rise to fewer and largely homogeneous DPSC
populations with more limited differentiation potential [38]. Research from this group
confirmed these findings and has used the direct outgrowth method for all subsequent
isolation procedures [15].
Within these heterogeneous populations of DPSC derived from the pulp of
permanent dentition, there are more specific sub-populations that include stem cells from
the apical papilla (SCAP), dental follicle (DFSC), periodontal ligament (PDLSC), as well
as non-specific DPSCs [39,40]. The dental papilla contributes to tooth formation and
becomes part of the dental pulp tissue in the mature dentition. Stem cells isolated from
the dental papilla (SCAP) have been demonstrated to produce dentin and cementum in
animal models and have been shown to express comparatively higher levels of the
survivin protein, as well as a unique cell surface marker (CD24) not found in other dental
derived stem cells [41].
However, stem cells have also been isolated from the dental follicle, more
specifically from the peridontium surrounding third molars prior to eruption, which are
capable of differentiation into bone lineages with expression of osteocalcin and bone
sialoprotein, and can be separated based upon their comparatively higher expression of
insulin-like growth factor (IGF-2) [42]. Finally, stem cells derived from the periodontal
ligament (PDLSC) express the biomarkers STRO-1 and CD146 and are capable of
forming cementum-like cells, adipocytes and collagen forming cells [43]. Other research
7

from this group has confirmed these findings, suggesting that multiple sub-populations
and lineages may be derived from dental pulp and the associated tissues that has distinct
phenotype and differentiation capabilities and potential [44].
Culture and Cryopreservation
Finally, other research has suggested that ancillary factors, such as the choice of
media, the selection of early versus late passage cells, and cryopreservation techniques
may also influence the differentiation potential and proliferative capacity of DPSC
isolates [45]. For example, there is some evidence to suggest that no serum (serum-free)
media may facilitate the preferential selection and expansion of DPSC bearing specific
stem cell biomarkers, while other studies found similar results using low or limited serum
media [46,47]. In addition, the selection of early- versus late-passage populations may
also preserve a more diverse array of potential DPSC sub-populations, which has been
repeatedly confirmed in more recent studies [48-51]. Finally, some evidence suggests that
cryopreservation methods and materials may also directly influence the survival rate and
therapeutic potential of DPSC, suggesting more research into this area may be needed
[52-54].
Conclusions
Although there are several for-profit organizations that have begun to offer
services specific for the extraction, processing and long-term storage of DPSC, evidence
based recommendations are limited regarding the viability and potential applications of
DPSCs in order to provide patients (and parents) interested in banking these tissues for
future possible usage. Due to the delicate nature of the isolation, culture and storage
8

process, extraction and processing fees, combined with the additional monthly long-term
storage, may result in costs that exceed many thousands of dollars before (or if) these
cells are needed. More research, however, will be needed for dental researchers and
clinicians to more fully explore the feasibility and potential for isolating and culturing
DPSCs extracted from adult human teeth in order to provide more accurate and informed
advice for this newly developing ﬁeld of regenerative medicine.
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CHAPTER 3
METHODOLOGY
Human Subjects
This original protocol for this study titled “Isolation of Non-Embryonic Stem
Cells from Dental Pulp” at the University of Nevada, Las Vegas School of Dental
Medicine (UNLV-SDM) dental clinic was approved by the UNLV Office of Research
Integrity Human Subjects (OPRS#0907-3148) in February 2010 [15, 16]. In brief, the
samples for this study were isolated from patients that were randomly recruited by
members of the UNLV-SDM clinic during their dental visits between February and June
2010. Informed Consent was required and was conducted onsite at the time of study
recruitment. Inclusion criteria: All patients were required to be consenting adults (> 18
years old) who agreed to participate. In addition, all dental pulp samples were collected
from subjects with sound, unrestored, vital teeth (teeth that have healthy pulp tissue), who
were already scheduled to have one or more extractions that were necessary for oral
health, as determined by the clinical faculty member in charge. Exclusion criteria: Any
subject under eighteen (18), any subjects scheduled for dental extractions involving
compromised pulp, and any subject that refused to donate their extracted teeth or
participate in this study.
DPSC Isolation and Culture
The teeth included in this retrospective study were originally extracted due to
impaction (e.g., third molars) or crowding (e.g., premolars extracted for orthodontic
treatment). Following extraction, the teeth were sectioned at the cemento-enamel junction
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(CEJ) using a diamond rotary disc and the dental pulp was removed with an endodontic
broach and then immediately placed into sterile microcentrifuge tubes containing 1X
phosphate buffered saline (PBS) and transferred to the laboratory for culture. Tubes were
pre-assigned a unique, randomly-generated number to maintain patient confidentiality
and to prevent research bias. The dental pulp samples were then transferred to a
biomedical laboratory for processing and culture using the direct outgrowth (DPSC-OG)
method [37, 55]. In brief, the PBS containing extracted dental pulp was centrifuged at 2.1
relative centrifugal force (RCF) and then resuspended in 1.0 mL of RPMI-1640 medium
from Hyclone (Logan, UT) with 2mM L-Glutamine, adjusted to contain 1.5 g/L sodium
bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate. Media was
supplemented with 1% Penicillin (10,000 units/mL), Streptomycin (10,000 mg/mL)
solution and 10% fetal bovine serum (FBS), obtained from HyClone (Logan, UT). Cells
were cultured in 75 cm2 BD Falcon tissue-culture treated flasks (Bedford, MA) at 37°C
and 5% CO2 in humidified chambers. Media was changed every 48 hours until adherent
cells reached 70% confluence. Cells were subsequently passaged at a 1:4 ratio for a
minimum of ten passages.
RNA Isolation and RT-PCR
To determine if the cells from each dental pulp isolate (remaining after ten
passages) were dental pulp stem cells (DPSC), RNA was isolated from 1.5 x 107 cells of
each of the experimental cell lines, using ABgene Total RNA Isolation Reagent (Epsom,
Surrey, UK) in accordance with the procedure recommended by the manufacturer [56].
RNA concentration and purity were calculated using UV spectroscopy. RT-PCR was then
performed on total RNA using the ABgene Reverse-iT One-Step RT-PCR Kit
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(ReadyMix Version) and a Mastercycler gradient thermocycler (Eppendorf: Hamburg,
Germany) using the mesenchymal stem cell (MSC) primers for CD44, CD133, NANOG,
Oct4, Sox-2, Bin1, Rnf12, and Klf4 synthesized by SeqWright (Houston, TX), as
previously described [15,16,57]. Reaction products were separated by gel electrophoresis
using Reliant 4% NuSieveR 3:1 Plus Agarose gels (Lonza: Rockland, ME). Bands were
visualized by UV illumination of ethidium-bromide-stained gels and captured using a
Kodak Gel Logic 100 Imaging System and 1D Image Analysis Software (Eastman
Kodak: Rochester, NY). Quantitation of RT-PCR band densitometry and relative mRNA
expression levels were performed using Adobe Photoshop (San Jose, CA) imaging
software, Image Analysis tools. All four (4) cell lines used in this study were found at
baseline to express intracellular (NANOG, Oct4, Sox-2, Klf4, Rnf12, Bin1) and cell
surface markers (CD44, CD133) that are used to identify and characterize DPSC isolates.
Baseline Growth and Doubling Time
Assays to ascertain doubling time (DT) were performed in the appropriate
complete media. In brief, cells at 70% confluence were trypsinized and plated 1:4 into
new 75 cm2 BD Falcon tissue-culture treated flasks (Bedford, MA) at 37°C and 5% CO2
in humidified chambers and their confluence was measured with a Zeiss Axiovert 40
inverted microscope (Gottingen, Germany). Three separate, independent replications of
each experiment were performed to determine doubling time for each DPSC isolate.
Experimental Assays
Proliferation and differentiation assays were performed in the appropriate
complete media, with and without the addition of exogenous growth factors (GF) or
12

extracellular matrix (ECM), in Corning Costar 12-well assay plates (Corning, NY) at a
concentration of 1.2 x 106 cells per well, and proliferation was measured over twenty four
(24) days. Cultured cells were fixed at five time points, at the initial plating (T1), after six
(6) days (T2), after twelve (12) days (T3), after (18) days (T4) and after twenty four (24)
days (T5), using 50 mL of 10% buffered formalin. For experimental plates fixed at each
time point, the formalin was aspirated after twenty four (24) hours and each cell well was
then stained with crystal violet 1% aqueous solution (Fisher Scientific: Fair Lawn, NJ).
The stain was then aspirated and wells washed with 1X phosphate buffered saline (Fisher
Scientific: Fair Lawn, NJ) and aspirated. The relative absorbance was then measured at
630 nm using a Bio-Tek ELx808 microplate reader (Winooski, VT). Data were analyzed
and graphed using Microsoft Excel (Redmond, WA). Three separate, independent
replications of each experiment were performed.
Materials
Two direct methods for induction of DPSC isolate differentiation in vitro were
utilized: 1) the addition of exogenous growth factors (GF), and 2) the coating of specific
extracellular matrix molecules (ECM) onto the surface of tissue-culture dishes, which
were performed for each of the experimental assays described above. As previous
research has demonstrated transforming growth factor (TGF-b1; M.W. 44.3 kDA) may,
in fact, be critical to maintaining DPSC pluripotency, TGF-b1 was obtained from
Calbiochem (La Jolla, CA) and the cellular media supplemented to a final concentration
of 2.5 ng/mL or 0.56 uM [18]. In addition, one of the primary methods for GF induced
differentiation of DPSC and MSC isolates, Dexamethasone (Dex) was obtained from
Fisher Scientific (Fair Lawn, NJ) and added to cellular media for a final concentration of
13

10 nM [58,59]. Finally, the control for the GF experiments was the MEK1 inhibitor (40
ng/mL or 50 mM), a cell-cycle and growth factor inhibitor, obtained from
Calbiochem/EMD Biosciences/Millipore, M.W. 267.3 (Darmstadt, Germany) [57].
Extracellular matrix (ECM) molecules were obtained from Fisher Scientific (Fair Lawn,
NJ) and tissue culture wells were coated with purified ECM at a 20 ug/mL protein
concentration for one hour (60 minutes) at room temperature (25 C), as previously
described. Poly-L-lysine (34-382-0001), Collagen-1 (50- 361-599) and Laminin-5
(NC9992259) [59-62]. Data were analyzed and graphed using Microsoft Excel
(Redmond, WA).
Statistical Analysis
The differences between treatments were measured using a t distribution, p= 0.05.
All samples were analyzed using two-tailed t-tests as departure from normality can make
more of a difference in a one-tailed than in a two-tailed t-test [63]. As long as the sample
size is at least moderate (>20) for each group, quite severe departures from normality
make little practical difference in the conclusions reached from these analyses.
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CHAPTER 4
RESULTS
Four (4) previously characterized dental pulp stem cell lines were thawed and
subsequently grown in culture to assess their baseline growth and doubling time (Figure
1) [15,16]. The average doubling time was 2.83 days, which ranged between 2.05 to 3.87
days. For the in vitro differentiation experiments, each cell line (DPSC-3882, 5653, 9765,
and 11418) was then plated into 96-well tissue culture treated plates and evaluated using
photomicroscopy to determine any changes to cellular morphology, as well as cellular
number and doubling time. In these 24-day assays, from the initial time point (T1) to the
final endpoint (T5), each of the four DPSC cell lines grew from less than 5% confluence
(Figure 3) to approximately 34% confluence (Figure 1). The addition of TGF-b1, recently
demonstrated to maintain or increase pluripotency in DPSC, was associated with
accelerated growth of approximately 55% in these cell lines (Figure 2) [58, 59]. The
average doubling time decreased by 27.3% from 2.83 to 2.2 days, ranging between 1.1 to
4.09 days. Although doubling time in one cell line (DPSC-5653) did not exhibit a
significant change (3.87 to 4.09 days), doubling time in DPSC-9765 (2.18 to 1.14 days),
DPSC- 3882 (3.24 to 2.22 days), and DPSC-11418 (2.05 to 1.35 days) decreased
markedly (n=24, p<0.05). Although significant changes to the rates of cellular growth
were observed with the addition of TGF-b1, no overt changes to cellular morphology or
size were observed in any cell line (Figure 3). Following previous research that
demonstrated induction of MSC and DPSC differentiation in vitro using specific
extracellular matrix (ECM) molecules and growth factors, these methods were utilized to
ascertain any effects on cellular phenotype or growth in these DPSC isolates (Figure 4)
15

[58-62]. The addition of growth factors to the cell culture medium induced variable
responses in the DPSC isolates. As previously noted, TGF-b1 increased the doubling time
and proliferation in all DPSC isolates by approximately 50% (range: 1.32 – 1.91 fold
increase), although no overt changes to cellular morphology were observed. The addition
of the MEK1 inhibitor PD98059 was not sufficient to induce any overt changes to any of
the DPSC isolates (Figure 5). However, the addition of Dexamethasone (Dex) was
sufficient to induce a differential response in DPSC-9765 and DPSC-11418, but not in
DPSC-3882 or DPSC-5653 (Figure 6). More specifically, growth in DPSC-9765 was
increased by 2.03 fold while proliferation of DPSC-11418 increased by 2.31 fold, which
was significantly higher than the growth observed in DPSC-3882 or DPSC-5653
(p<0.05), which was also correlated with changes to cellular morphology and the
formation of dense accumulations of localized, site-specific aggregations of larger cells
with visibly altered morphology.
The wells coated with the ECM control poly (PLL) (Figure 7) and the
experimental wells coated with Collagen 1 (CG1) did not induce any changes to cell
number or morphology in any of the four cell lines (Figure 8). However, a differential
response was noted in the wells coated with Laminin-5 (LN5) with two DPSC isolates
exhibiting both an increase in cell number, as well as significant changes to the
morphology of some subsets of cells. More specifically, LN5 was sufficient to induce an
increase in growth in DPSC-3882 and DPSC-5653 by more than two-fold (2.24 and 2.29
respectively), which was significantly different than the growth observed in the other
DPSC isolates and from the baseline measurements (p< 0.05) (Figure 9).

16

In order to evaluate and assess the differential phenotypic changes observed under
Dexamethasone administration and Laminin-5 plating, RNA was successfully isolated
from all DPSC isolates under conditions and relative endpoint (RE) reverse transcription
polymerase chain reaction (RT-PCR) was performed using equal concentrations of total
RNA from each isolate. These analyses revealed that mRNA specific for the intracellular
biomarkers for DPSC, Klf4 and Sox well as the cell surface marker CD133, were
expressed in DPSC-3882, DPSC-5653, DPSC-9765 and baseline. Additional mRNA
biomarkers, including Bin Rnf12, Oct-4 and NANOG were also expressed (Figures 1014). The relative levels of these intracellular and extracellular biomarkers were enhanced
following the administration of TGF-β1. However, the differential phenotypes observed
under Dexamethasone and Laminin administration were associated with differential
expression of these same biomarkers.
More specifically, the altered the growth and phenotype of DPSC-9765 and
DPSC-11418 following Dexamethasone administration was correlated with a loss of
mRNA for the transcriptional control regulator Klf4 (as well as Bin1 and Rnf12). In
addition, expression of mRNA specific for the downstream biomarkers Sox-2 (as well as
Oct4 and NANOG) and CD133 was also down-regulated with previous observations of
apical papilla (AP) dental follicle (DF) derived DPSCs that are responsive to GF induced
methods for in vitro differentiation. However, no significant changes to these biomarkers
were observed in either DPSC-3882 or DPSC-5653, the DPSC isolates non-responsive to
Dexamethasone.
Conversely, the altered phenotypes observed in DPSC-3882 and DPSC-5653
following plating on Laminin-5 coated dishes were associated with a downregulation (but
17

not loss) of mRNA expression in both Klf4 and Sox-2 (as well as Bin1, Rnf12, Oct4, and
NANOG; (Figures 10-12). Expression of mRNA for the downstream cell surface DPSC
biomarker CD133, however, was only slightly reduced in the DPSC-3882 isolate,
although this expression was completely lost in DPSC-5653. These results appear to be
consistent with previous observations that periodontal ligament (PD)-derived DPSC
isolates may be primarily responsive to ECM-mediated methods for in vitro
differentiation.
CHAPTER 5
DISCUSSION AND CONCLUSIONS
Discussion
The goal of this project was to evaluate the potential to induce differentiation
among DPSC isolates from four (4) orthodontic patients using established MSC and
DPSC protocols and methods. These results demonstrated that all four DPSC isolates
exhibited phenotypes and expressed biomarkers at baseline consistent with MSC and
DPSC and also responded appropriately to the pluripotency sustaining effects of in vitro
TGFb1 administration [58, 59]. However, the two primary methods for inducing
differentiation, ECM plating and GF administration [58-62], exhibited differential
responses in these DPSC isolates. That these DPSC isolates were susceptible to the
effects of either ECM- or GF-induced alterations to growth, proliferation, morphology
and DPSC biomarker expression, suggests that these methods may be sufficient to
stimulate these responses in some DPSC isolates, although not universally. More
importantly, that the specific type of DPSC isolate (influenced by the method of isolation
and culture) may be, in fact, a critical component for a more complete understanding of
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how these methods could be employed to evaluate the potential lineages and usages for
any given patient [14,37,55]. For example, these findings complement the ever expanding
body of research that suggests DPSC isolates are often not heterogeneous aggregations of
DPSCs but may, in fact, be clones derived from different and often very specific subsets
of DPSCs, such as AP-DPSC, DF-DPSC or PDL-DPSC [37,55]. Many factors influence
DPSC quality and quantity and type, including the methods used to isolate, collect,
concentrate, and store these isolates [1]. For instance, isolation by enzymatic dissociation
(DPSC-ED) may be more likely to produce heterogeneous populations of faster growing
cells, as this process allows for dissociation of multiple cell types from the extracted
dental pulp, although this process may limit viability and may also decrease overall yield
[11,14]. In contrast, DPSC isolation by direct outgrowth (DPSC-OG), the method
employed in this study, tends to produce largely homogenous populations of one DPSC
type, with more limited differentiation potential due to their random selected clonal
derivation [15, 16]. This study had several limitations that should be outlined, including a
very limited sample size (n=4), which may restrict the overall ability to make inferences
about these results. In addition, the DPSC isolates were derived from adult orthodontic
patients, which may have different health outcomes and parameters than other dental
patient populations, which could also influence the overall results and outcomes
associated with this study [56]. Finally, this was a retrospective analysis of previously
collected DPSC isolates, therefore, prospective studies that incorporate larger sample
sizes will be needed to further elucidate the parameters that most likely influence the
differentiation potential for DPSC isolates from dental patients.
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Conclusions
Although some commercial enterprises now offer DPSC banking and storage
services, much less is known about the viability or potential applications for DPSCs
isolated from dental patients. Although many patients routinely have intact, adult teeth
extracted for orthodontic and other dental-related issues, few studies have addressed the
potential to characterize the potential for these isolates to be manipulated in laboratory
settings. This study provides some initial evidence that randomly selected DPSC isolates
from orthodontic patients may be induced by established protocols to change phenotype
and expression of pluripotent biomarkers with variable susceptibility between differing
types of DPSCs, although more studies will be needed to determine the range of cell
types that can be successfully re-engineered in laboratory settings.
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Recommendations for further research
Stem Cell therapy is being used to treat life threatening conditions around the
world, and the full breath of stem cell therapy has only just begun to be discovered. In the
last several years there has been a tremendous increase in our knowledge of
bioengineering of DPSCs. The usefulness of these cells is being uncovered exponentially
as researchers work together as a multidisciplinary team across many fields to continue
progress in this work. In this study and in others across the world, we are seeing evidence
that suggests that tissue regeneration is no longer an unattainable dream. The application
of this knowledge in medicine and dentistry will allow practitioners to increase the
quality of life for mankind.
This work is among the first to demonstrate that Dexamethasone and Laminin-5
may be sufficient to induce partial DPSC differentiation. It is also among the first to show
that TGF-β1 notably increases pluripotency in DPSCs. The search for the ideal
combination of cells, scaffolds, and morphogenic factors for the engineering of tissues
from DPSCs is the focus of immediate future research. Using the knowledge we have
gained in this study, it seems natural to move forward with the combination of the
substrates we have used to see how differentiation of DPSCs occurs through these
modalities. Prospective studies including multiple DPSC lines could be exposed to both
Dexamethasone and TGF-β1, and Laminin-5 and TGF-β1 in combination to observe the
changes in the cells. It would be interesting to observe if the increased pluripotency we
noted with exposure to TGF-β1 would induce increase number of cells that differentiated
or if the speed of differentiation changed when DPSCs are exposed to these proposed
combinations of substrates. Once clear protocols are established that allow for predictable
21

differentiation of cells into specific tissue forming cells, work can begin on advances that
will likely progress into the biologic regeneration of oral tissues such as producing a
scaffold to induce tissue growth into a particular shape and/or laying down of patterns of
homeobox genes within these scaffolds to induce formation of layers of tissues. The
future of research in this discipline is exciting and the advances that will unfold in the
next decade will bring much progression in medicine and dentistry.
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APPENDIX A
FIGURES RELATED TO THE RESEARCH QUESTIONS

Figure 1/ Figure 2. Base line DPSC proliferation is enhanced in vitro by the addition of
TGF B1. Initial plating of cells (T1) revealed an average confluence of approximately
5%. Baseline growth (without the addition of growth factors) demonstrated an average
doubling time of 2.83 days (DPSC-5633: 3.87d; DPSC-3882: 3.24 d; DPSC-11418:
2.05d) for a final confluence at the final time point (T5) of approximately 34%. (Figure
1) The addition of TGF-B1 increased growth at T5 to approximately 53% and decreased
average doubling time to 2.21 days (DPSC-9765: 1.14d; DPSC-5653; 4.09 d; DPSC3882: 2.22d; DPSC-11418: 1.35 d). (Figure 2).
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Figure 3. The addition of TGF-β1was associated with accelerated growth of
approximately 55% in all four cell lines. Although significant changes to the rates of
cellular growth were observed with the addition of TGF- β1, no overt changes to cellular
morphology or size were observed in any cell line.
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Figure 4. DPSC cellular phenotypes altered by exogenouf factors. The addition of
extracellular matrix coated wells or growth factor was sufficient to indue changes to
some DpSC isoates. As previously noted, TGF-β1 increased growth in all four isolates
with no changes observed in cellular morphology.
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Figure 5. Base line DPSC plated with MEK 1 Inhibitor (T1). No change seen in cell
morphology over time points (T3) and (T5).
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Figure 6. Base line DPSC plated with Dexamethasone (T1).Significant changes to
cellular morphology and increased growth over time points (T3) and (T5) was seen in cell
lines DPSC 9765 and DPSC 11418.
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Figure 7. Base line DPSC plated with Poly-L-lysine (T1). No change seen in cell
morphology over time points (T3) and (T5).
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Figure 8. Base line DPSC plated with Collagen and Vitronectin (T1). No change seen in
cell morphology over time points (T3) and (T5).
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Figure 9. Base line DPSC plated with Laminin 5 (T1).Significant changes to cellular
morphology and increased growth over time points (T3) and (T5) was seen in cell lines
DPSC 3882 and DPSC 5653.
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Figure 10. The addition of extrcellular matrix Laminin-5 coated wells was sufficient to
inhibit Cox-4 and Sox-2 intracellular mRNA expression in DPSC-3882 and DPSC-5653
cell lines.

31

Figure 11. The addition of extrcellular matrix Laminin-5 coated wells was sufficient to
inhibit Rnf, Bin, and Klf intracellular mRNA expression in DPSC-3882 and DPSC-5653
cell lines.
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Figure 12. The addition of extrcellular matrix Laminin-5 coated wells was sufficient to
inhibit CD133 cell surface marker expression in DPSC-3882 and DPSC-5653 cell lines.
CD44 (Control) cell surface marker was maintained.
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Figure 13. The addition of growth factor Dexamethasone was sufficient to inhibit Sox-2
intracellular mRNA expression in DPSC-9765 and DPSC-11418 cell lines. Oct-4
expression was altered with an alternative (shorter) transcript expressed and at
significantly higher levels.
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Figure 14. The addition of growth factor Dexamethasone was sufficient to inhibit Rnf,
Bin, and Klf intracellular mRNA expression in DPSC-9765 and DPSC-11418 cell lines.
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